(Q44325301)

English

Simultaneous separation of fifteen approved protease and reverse transcriptase inhibitors for human immunodeficiency virus therapy by capillary electrophoresis

scientific article published in February 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Simultaneous separation of fifteen approved protease and reverse transcriptase inhibitors for human immunodeficiency virus therapy by capillary electrophoresis (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Heribert Stoiber

4

object named as

Heribert Stoiber

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Barbara Falkensammer

5

object named as

Barbara Falkensammer

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

author name string

Nguyen Duc Tuan

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Wolfgang Gutleben

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Karin Scherer

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Manfred P Dierich

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Andreas Zemann

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Electrophoresis

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

662-670

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

describes a project that uses

capillary electrophoresis

1 reference

based on heuristic

inferred from title

Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro screening of nucleoside analog combinations for potential use in anti-HIV therapy

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid quantification of indinavir in human plasma by high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous determination of ritonavir and saquinavir, two human immunodeficiency virus protease inhibitors, in human serum by high-performance liquid chromatography.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of saquinavir in human plasma, saliva, and cerebrospinal fluid by ion-pair high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

High-performance liquid chromatographic determination of ritonavir in human plasma, cerebrospinal fluid and saliva.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

Simple high-performance liquid chromatographic determination of the protease inhibitor indinavir in human plasma

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

High-performance liquid chromatographic method for the simultaneous determination of HIV-1 protease inhibitors indinavir, saquinavir and ritonavir in plasma of patients during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extractio

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

Sensitive liquid chromatographic assay for amprenavir, a human immunodeficiency virus protease inhibitor, in human plasma, cerebrospinal fluid and semen

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of indinavir in human cerebrospinal fluid and plasma by solid-phase extraction and high-performance liquid chromatography with column switching

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

High-performance liquid chromatography of HIV protease inhibitors in human biological matrices

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of human immunodeficiency virus-1 protease inhibitors in patient serum using free solution capillary zone electrophoresis

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

Capillary electrophoretic separation of protease inhibitors used in human immunodeficiency virus therapy

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination at ppb level of an anti-human immunodeficiency virus nucleoside drug by capillary electrophoresis-electrospray ionization tandem mass spectrometry.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous quantitation of nucleoside HIV-1 reverse transcriptase inhibitors by short-end injection capillary electrochromatography on a beta-cyclodextrin-bonded silica stationary phase.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

Electrokinetic separations with micellar solutions and open-tubular capillaries

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

Capillary electrophoresis of proteins in buffers containing high concentrations of zwitterionic salts

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

Preformulation studies of a novel HIV protease inhibitor, AG1343.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200390078

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/ELPS.200390078

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44325301&oldid=2109453291"